Indonesia Health Access & Policy Strategy Lead

F. Hoffmann-La Roche AG; Pluit; On-site; IDR 1,200,000,000 - 2,400,000,000; Full time

Job summary

Roche is seeking a Chapter Lead in Indonesia to shape medicines access strategy, ensuring patients can reach Roche therapies through public policy and health system engagement.

You will sit on Indonesia's Leadership Team, build relationships with government bodies and authorities, drive formulary listings, and lead a team with integrity and strategic impact. The role emphasizes collaboration across regions and patient impact.

Qualifications

• University degree in a relevant field; MBA is a plus.
• Experience engaging senior stakeholders across complex organizations.
• Strong analytical and business presentation skills.
• Proven people leadership and development ability.

Responsibilities

• Build productive relationships with government bodies and patient groups to improve access nationally.
• Lead development of public policy strategies for healthcare investment and access.
• Oversee formulary listing processes and expand access to Roche therapies.
• Shape communications strategy reflecting long-term business priorities.
• Represent Roche in industry groups and collaborate across regions.
• Lead early strategic analysis of local market potential for new therapies.
• Coach and develop the team, fostering collaboration and growth.

Skills

Strategic leadership

Stakeholder management

Public policy

Healthcare economics

Communication skills

Team leadership

Education

University degree in life sciences/public health/political science/business

MBA (plus)

Job description

Roche is seeking a Chapter Lead in Indonesia to shape medicines access strategy, ensuring patients can reach Roche therapies through public policy and health system engagement.

You will sit on Indonesia's Leadership Team, build relationships with government bodies and authorities, drive formulary listings, and lead a team with integrity and strategic impact. The role emphasizes collaboration across regions and patient impact.